Free Trial

Xylem (XYL) Stock Forecast & Price Target

Xylem logo
$149.85 0.00 (0.00%)
Closing price 03:59 PM Eastern
Extended Trading
$149.85 +0.00 (+0.00%)
As of 06:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Xylem - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
5
Buy
9

Based on 14 Wall Street analysts who have issued ratings for Xylem in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 5 have given a hold rating, 8 have given a buy rating, and 1 has given a strong buy rating for XYL.

Consensus Price Target

$152.33
1.66% Upside
According to the 14 analysts' twelve-month price targets for Xylem, the average price target is $152.33. The highest price target for XYL is $175.00, while the lowest price target for XYL is $130.00. The average price target represents a forecasted upside of 1.66% from the current price of $149.85.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for XYL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Xylem and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XYL Analyst Ratings Over Time

TypeCurrent Forecast
10/6/24 to 10/6/25
1 Month Ago
9/6/24 to 9/6/25
3 Months Ago
7/8/24 to 7/8/25
1 Year Ago
10/7/23 to 10/6/24
Strong Buy
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
9 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$152.33$152.29$143.71$149.67
Forecasted Upside1.66% Upside8.37% Upside9.27% Upside12.14% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

XYL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

XYL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Xylem Stock vs. The Competition

TypeXylemBusiness Services CompaniesS&P 500
Consensus Rating Score
2.71
2.08
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside1.91% Upside96.36% Upside168.87% Upside
News Sentiment Rating
Positive News

See Recent XYL News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
9/27/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B)
9/22/2025Zacks Research
0 of 5 stars
 UpgradeHoldStrong-Buy
9/19/2025Barclays
3 of 5 stars
William Grippin
William Grippin
Not Rated
Initiated CoverageOverweight$165.00+15.90%
9/12/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$125.00 ➝ $140.00-1.22%
8/26/2025Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingHold
8/26/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetHold$125.00 ➝ $130.00-8.93%
8/5/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$164.00 ➝ $168.00+15.98%
8/1/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$162.00 ➝ $175.00+23.51%
7/14/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$137.00 ➝ $152.00+16.17%
5/30/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$148.00+17.85%
5/15/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
4/30/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$143.00 ➝ $147.00+23.38%
4/30/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$149.00 ➝ $146.00+23.38%
12/12/2024Wolfe Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperformPeer Perform
5/31/2024Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOutperform$147.00 ➝ $152.00+9.71%
5/29/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$146.00 ➝ $165.00+19.75%
3/12/2024BNP Paribas
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageOutperform$150.00+18.88%
11/21/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeHoldBuy$104.00 ➝ $120.00+19.74%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:42 PM ET.


Should I Buy Xylem Stock? XYL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, October 6, 2025. Please send any questions or comments about these Xylem pros and cons to contact@marketbeat.com.

Xylem
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Xylem Inc.:

  • The current stock price is around $149, reflecting a strong market position and investor confidence in the company's growth potential.
  • Xylem Inc. reported earnings per share of $1.26, exceeding analysts' expectations, indicating robust financial performance and effective management.
  • The company has shown a year-over-year revenue increase of 6.1%, suggesting a positive growth trajectory and resilience in its business model.
  • Xylem Inc. has a solid dividend yield of approximately 1.1%, providing investors with a steady income stream, which is particularly attractive in volatile markets.
  • Analysts have a consensus rating of "Moderate Buy" for Xylem Inc., with several upgrades indicating strong future performance expectations.

Xylem
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Xylem Inc. for these reasons:

  • The price-to-earnings ratio of 38.71 may suggest that the stock is overvalued compared to its earnings, which could deter value-focused investors.
  • Despite positive earnings, the company's net margin of 10.74% may indicate limited profitability, raising concerns about long-term sustainability.
  • Institutional investors hold a significant 87.96% of the company's stock, which could lead to volatility if large shareholders decide to sell.
  • Recent insider selling, including a notable transaction by the chief accounting officer, may raise red flags about the company's future prospects.
  • The company's guidance for FY 2025 EPS is set at 4.700-4.850, which may not meet investor expectations if market conditions change.

XYL Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Xylem is $152.33, with a high forecast of $175.00 and a low forecast of $130.00.

14 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Xylem in the last year. There are currently 5 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" XYL shares.

According to analysts, Xylem's stock has a predicted upside of 1.66% based on their 12-month stock forecasts.

Over the previous 90 days, Xylem's stock had 1 upgrade by analysts.

Xylem has been rated by research analysts at Barclays, Citigroup, Cowen, Mizuho, Stifel Nicolaus, TD Cowen, UBS Group, Weiss Ratings, and Zacks Research in the past 90 days.

Analysts like Xylem more than other "business services" companies. The consensus rating for Xylem is Moderate Buy while the average consensus rating for "business services" companies is Hold. Learn more on how XYL compares to other companies.


This page (NYSE:XYL) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners